Education
About Us
Working with TipRanks
Follow Us
MedCap AB (DE:61MA)
FRANKFURT:61MA
Total Valuation
MedCap AB has a market cap or net worth of €564.82M. The enterprise value is €8.93B.
Market Cap€564.82M
Enterprise Value€8.93B
Share Statistics
MedCap AB has 14,981,353 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14,981,353
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MedCap AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee4.91M
Profits Per Employee739.95K
Employee Count368
Asset Turnover0.91
Inventory Turnover2.79
Valuation Ratios
The current PE Ratio of MedCap AB is 42.97. MedCap AB’s PEG ratio is 2.12.
PE Ratio42.97
PS Ratio3.62
PB Ratio6.95
Price to Fair Value6.95
Price to FCF30.34
Price to Operating Cash Flow24.76
PEG Ratio2.12
Income Statement
In the last 12 months, MedCap AB had revenue of 1.81B and earned 207.40M in profits. Earnings per share was 13.99.
Revenue1.81B
Gross Profit1.06B
Operating Income272.30M
Pretax Income261.60M
Net Income207.40M
EBITDA396.00M
Earnings Per Share (EPS)13.99
Cash Flow
In the last 12 months, operating cash flow was 360.10M and capital expenditures -66.20M, giving a free cash flow of 293.90M billion.
Operating Cash Flow360.10M
Free Cash Flow293.90M
Free Cash Flow per Share19.62
Dividends & Yields
MedCap AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.09
52-Week Price Change0.27%
50-Day Moving Average33.52
200-Day Moving Average42.50
Relative Strength Index (RSI)65.11
Average Volume (3m)0.00
Important Dates
MedCap AB upcoming earnings date is May 2, 2025, TBA Not Confirmed.
Last Earnings DateJan 31, 2025
Next Earnings DateMay 2, 2025
Ex-Dividend Date―
Financial Position
MedCap AB as a current ratio of 2.77, with Debt / Equity ratio of 27.93%
Current Ratio2.77
Quick Ratio1.96
Debt to Market Cap<0.01
Net Debt to EBITDA―
Interest Coverage Ratio14.33
Taxes
In the past 12 months, MedCap AB has paid 52.30M in taxes.
Income Tax52.30M
Effective Tax Rate0.20
Enterprise Valuation
MedCap AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
MedCap AB has €370.10M in cash and marketable securities with kr302.70M in debt, giving a net cash position of -€12.10M billion.
Cash & Marketable Securities€370.10M
Total Debtkr302.70M
Net Cash-€12.10M
Net Cash Per Share-€0.81
Tangible Book Value Per Share€41.89
Margins
Gross margin is 46.92%, with operating margin of 15.07%, and net profit margin of 11.48%.
Gross Margin46.92%
Operating Margin15.07%
Pretax Margin14.48%
Net Profit Margin11.48%
EBITDA Margin21.92%
EBIT Margin15.53%
Analyst Forecast
The average price target for MedCap AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―